Eli Lilly & Co. , facing generic competition to its top-selling drug Zyprexa this year, said it will tie cash bonuses for employees partly to the success of medicines the drugmaker is developing as it seeks new products.
Lunchtime at the flagship In-N-Out Burger restaurant in Baldwin Park, California, is a study in efficiency. As the order line swells, smiling workers swoop in to operate empty cash registers. Another staffer cleans tables, asking customers if they’re enjoying their hamburger. Outside, a woman armed with a hand-held ordering machine speeds up the drive-through line.
Eli Lilly & Co. , already facing competition next year for its top-selling drug, lost a court bid over patent protection on its cancer medicine Gemzar , which could lead to generic products as early as November.